Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Vaccinex, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q4 2021
- Shares held
- 4.25M
- +2.65M (+166.1%) vs. Q4 2021
- Total value
- $5.49M
- +$3.83M (+230.6%) vs. Q4 2021
- New holders
- 8
- 7 more added
- Sold out
- 4
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $45 |
| Q3 2024 | 12 | $1.14M |
| Q2 2024 | 11 | $1.81M |
| Q1 2024 | 12 | $2.39M |
| Q4 2023 | 18 | $1.07M |
| Q3 2023 | 19 | $2.92M |
| Q2 2023 | 23 | $994.8K |
| Q1 2023 | 24 | $1.10M |
| Q4 2022 | 25 | $3.12M |
| Q3 2022 | 22 | $2.28M |
| Q2 2022 | 27 | $5.03M |
| Q1 2022 | 25 | $5.49M |
| Q4 2021 | 21 | $1.66M |
| Q3 2021 | 23 | $3.36M |
| Q2 2021 | 28 | $4.54M |
| Q1 2021 | 33 | $2.79M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Vaccinex, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 110 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,160 | $1.00K | 0.00% | +860+286.7% | Added |
| Ancora Advisors, LLC | 2,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 3,500 | $5.00K | 0.00% | −800−18.6% | Reduced |
| Group One Trading, L.P. | 4,894 | $6.00K | 0.00% | +3,705+311.6% | Added |
| Royal Bank of Canada | 5,153 | $7.00K | 0.00% | +5,153 | New |
| Vectors Research Management, LLC | 10,000 | $13.0K | 0.00% | +5,000+100.0% | Added |
| Moors & Cabot, Inc. | 10,000 | $13.0K | 0.00% | +10,000 | New |
| HNP Capital LLC | 10,000 | $13.0K | 0.00% | +10,000 | New |
| Creative Planning | 11,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 14,351 | $19.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 16,534 | $21.0K | 0.00% | +16,534 | New |
| Northern Trust Corp | 16,702 | $22.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 16,823 | $22.0K | 0.00% | +16,823 | New |
| Millennium Management LLC | 30,879 | $41.0K | 0.00% | +30,879 | New |
| Susquehanna International Group, LLP | 34,521 | $46.0K | 0.00% | +12,485+56.7% | Added |
| BlackRock Inc. | 47,520 | $63.0K | 0.00% | −2,196−4.4% | Reduced |
| Worth Venture Partners, LLC | 66,856 | $88.0K | 0.04% | +66,856 | New |
| State Street Corp | 67,800 | $89.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 67,768 | $90.0K | 0.00% | −13,656−16.8% | Reduced |
| Point72 Asset Management, L.P. | 226,593 | $299.0K | 0.00% | −168,929−42.7% | Reduced |
| Geode Capital Management, LLC | 236,715 | $312.0K | 0.00% | +108,383+84.5% | Added |
| Telemetry Investments, L.L.C. | 540,000 | $713.0K | 1.14% | +407,000+306.0% | Added |
| Vanguard Group Inc | 727,265 | $960.0K | 0.00% | +104,083+16.7% | Added |
| AIGH Capital Management LLC | 2,081,801 | $2.63M | 0.95% | +2,081,801 | New |
| Natixis | 0 | $0 | 0.00% | −31,895−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −5,655−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,273−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −182−100.0% | Sold out |